The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

A MUM has revealed she has no regrets about spending £1,200 on confidence-boosting Mounjaro – despite being in £21,000 of ...

DOES it feel like you’ve tried everything in your quest to lose those final pounds? While the world is obsessed with ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market to American rival Eli ...

(Reuters) -Ozempic ... Insulin, and in 1987, the first human insulin products were made using genetically engineered yeast cells. Novo launched the NovoPen - the first insulin pen device in ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

ONTARIO, Canada, May 16, 2025 (EZ Newswire) -- Canadian Insulin, today shared insights about Ozempic (semaglutide) and the high cost of prescription medications in the U.S., which has been a major ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...